AFT agrees four new licensing deals for Maxigesic

27 November 2019 - Deborah Wilkes


AFT Pharmaceuticals is set to launch Maxigesic/Combogesic in Canada through a licensing deal with local firm BioSyent Pharma. The New Zealand company has also recently agreed deals for the combination pain reliever in Germany, Pakistan and Vietnam.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: